Celgene Corp. (CELG)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Mark J. Alles
Employees:
8852
86 MORRIS AVENUE, SUMMIT, NJ, 07901
(908)673-9000
• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
Date | Ratio |
---|---|
2004-10-25 | 2:1 |
2006-02-27 | 2:1 |
2014-06-26 | 2:1 |
Celgene Corp. is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. Its targeting areas include intracellular signaling pathways, protein homeostasis and epigenetics in cancer and immune cells, immunomodulation in cancer and autoimmune diseases and therapeutic application of cell therapies. The company's products include Revlimid, Vidaza, Thalomid, Pomalyst/Imnovid, Abraxane, and Istodax. Celgene was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|